The MARCH for Military Servicemembers Act repeals a specific federal law that previously restricted the use of Department of Defense medical facilities and funds for abortion care. By removing this restriction, the bill allows military healthcare providers to offer abortion services to servicemembers without fear of violating federal regulations. This change directly affects active duty personnel, reservists, and their dependents who rely on military healthcare systems. The legislation does not create new funding or mandate specific procedures but rather restores the ability of the Department of Defense to provide reproductive care consistent with other medical treatments.
The Rural MOMS Act of 2026 modifies how Medicare counts hospital beds, specifically excluding labor and delivery rooms from the total number of acute care inpatient beds used to determine if a facility qualifies as a Critical Access Hospital. This change directly affects rural hospitals that provide maternity services by altering the financial thresholds required to maintain their special status under the Medicare program. By removing delivery rooms from the bed count calculation, the bill aims to prevent these facilities from losing their designation solely because they offer childbirth care. The legislation does not change how these hospitals are funded or operated, but rather adjusts the metric used to evaluate their eligibility for critical access benefits.
The Blood Pressure MATTERS Act requires health insurance plans, Medicaid programs, and the Children's Health Insurance Program to cover self-measured blood pressure monitors for pregnant and postpartum individuals without charging copayments or deductibles. This coverage applies to devices that allow individuals to measure their own blood pressure without a doctor's help, provided the device is FDA-cleared and listed on a specific validated registry. The law mandates that these devices be covered regardless of whether a person has been diagnosed with high blood pressure, but limits the benefit to one device per person every two years. These changes take effect approximately 120 days after the bill is enacted, with a grace period for states that need to pass additional legislation to comply.
This Senate resolution formally recognizes Maternal Mental Health Day on the first Wednesday of May to raise awareness about mental health issues affecting new mothers. It highlights the prevalence of these conditions, noting that they are common complications of pregnancy that often go undiagnosed and can negatively impact both mothers and their children. The bill calls for increased public education on risk factors and symptoms, honors the challenges mothers face, and encourages further research and provider training to improve treatment options.
This bill, known as the Physician Education for Fistula Treatment Act, aims to prevent and treat obstetric fistula, a serious childbirth injury caused by prolonged labor without medical care, primarily affecting women in the world's poorest nations. It authorizes funding to train and retain obstetrician-gynecologists and urogynecology specialists in least developed countries through new fellowship programs, residency training, and specialized medical centers. Additionally, the legislation requires the President to create a comprehensive ten-year strategy to address the shortage of physicians in these regions, focusing on prevention, treatment, and strengthening local health infrastructure. The bill also mandates that relevant government agencies submit annual reports to Congress on the progress and effectiveness of these international health initiatives.
The Advancing Menopause Care and Mid-Life Women’s Health Act directs the National Institutes of Health and the Department of Health and Human Services to expand research, education, and clinical training focused on menopause and mid-life women’s health. It authorizes funding to create Centers of Excellence, launch public awareness campaigns, and develop training programs for health care providers to better diagnose and treat menopausal symptoms. The bill also requires the government to collect data on health disparities and report progress annually to Congress, with a specific focus on improving care for women in rural and underserved areas.
The Optimizing Postpartum Outcomes Act of 2026 directs the Department of Health and Human Services to issue guidance on Medicaid and CHIP coverage for pelvic health services, such as pelvic floor exams and physical therapy, during the postpartum period. This guidance will outline best practices for payment models, financing options, and technical assistance for state agencies to improve access to these care services. The bill also requires the Government Accountability Office to study gaps in coverage for these services and defines the postpartum period as lasting at least six months or as long as lactation continues. Additionally, the Act authorizes $2 million annually from 2027 to 2031 to fund a national education campaign that trains health professionals and informs postpartum women about the importance and availability of pelvic health care.
This bill establishes a grant program to help vulnerable mothers and babies in areas with high climate-related health risks, such as extreme heat and air pollution. It directs the Department of Health and Human Services to award up to $105 million over four years to community groups, healthcare providers, and local organizations for initiatives that provide cooling resources, health education, and support services. The program prioritizes areas with high rates of maternal and infant health disparities and requires grantees to address racial and ethnic inequities. Additionally, the bill creates a research consortium at the National Institutes of Health to study climate impacts on birth outcomes and funds training programs for health profession schools to better prepare providers for these risks.
This non-binding resolution expresses the House of Representatives' view that the FDA should regulate mifepristone, a medication used for abortion, based on scientific evidence rather than political pressure. It highlights over 25 years of data showing the drug is safe and effective when prescribed via telemedicine or dispensed by mail and pharmacy. The bill advocates for policies that ensure equitable access to this care, particularly for marginalized communities facing barriers due to state-level restrictions. By citing numerous studies and medical organizations, the resolution calls for transparent, science-based decisions to maintain current access methods.
The Maternal Health Pandemic Response Act allocates $190 million to the Centers for Disease Control and Prevention and other federal agencies to improve maternal health data collection and research during public health emergencies. This funding supports efforts to track how infectious diseases affect pregnant and postpartum individuals, with a specific focus on collecting and sharing detailed demographic information to address disparities among racial and ethnic minority groups. The bill also establishes a task force to develop guidelines for respectful maternity care, which includes recommendations on telehealth access, doula coverage, and addressing issues like racism and intimate partner violence in healthcare settings. Additionally, the legislation mandates that the government publicly release deidentified data on maternal health outcomes at least monthly during emergencies to help communities make informed decisions.